BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Vasigrobart readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Vasigrobart\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07318597-547@assetmemo.bio
DTSTAMP:20261121T004521Z
DTSTART;VALUE=DATE:20280227
DTEND;VALUE=DATE:20280228
SUMMARY:Vasigrobart: Phase 2 readout est. (NCT07318597)
DESCRIPTION:Vasigrobart\, phase 2\, Pulmonary Arterial Hypertension.\nStudy
 : Study of REGN13335 in Adult Participants With Pulmonary Arterial Hyperte
 nsion (PAH)\nEstimated primary completion: 27 February 2028. This is a Cli
 nicalTrials.gov estimate\, not a confirmed readout date\, and it can move.
 \nDrug page: https://assetmemo.bio/drug/vasigrobart#upcoming-events\nRegis
 try record: https://clinicaltrials.gov/study/NCT07318597
URL:https://assetmemo.bio/drug/vasigrobart#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
